Купить акции iPROMOMED (PRMD): цена сегодня, график и показатели онлайн
                Moscow Exchange

                iPROMOMED

                Common stockPRMD

                The issuer is a participant in the  
                Shareholder Value Creation Program

                iPROMOMED is a public company whose securities are admitted to trading on Moscow Exchange. Equity type: Common stock, ticker: PRMD.
                The security is in the Level 2 List, confirming its compliance with the MOEX requirements. Standard lot size: 1. Trade currency: RUB.
                ISIN: RU000A108JF7.

                Stock price dynamics

                Common stock
                PRMD
                Advanced graph for professionals
                Trading data is displayed with a delay of 15 minutes.
                Please subscribe
                 to receive real-time market data
                Daily

                Trading volume

                -

                Day's Range

                -

                Value of equity

                -

                Trading data is displayed with a delay of 15 minutes

                Overview

                End-of-Day Data
                Security code
                PRMD
                Trading Mode ID
                TQBR
                Trading Mode Name
                T+: stocks, DRs - order-driven
                Qualified investors
                No
                Full name
                iPROMOMED
                Short name
                iPROMOMED
                State registration number
                1-01-01622-G
                Face value
                1
                Face value currency
                RUB
                Issue Size
                212,500,000
                ISIN Code
                RU000A108JF7
                List level
                2
                Lot
                1
                Date of listing
                12.07.2024
                Admission to the morning additional trading session
                Yes
                Admission to the evening additional trading session
                Yes
                Admission to the weekend additional trading session
                Yes
                Security
                A
                Group of Instruments
                EQIN
                Trade settle date
                17.07.2026
                View
                Instrument History

                More About the Issuer

                Issuer Profile
                Name
                PROMOMED PJSC
                Taxpayer ID
                9702034818
                In Brief
                Биофармацевтическая компания, реализующая концепцию полного цикла производства
                Company website
                Continue to site
                Issuer Disclosure Page
                Continue to site
                Issuer Reporting
                View
                Disclosure Violations
                Check
                Issuer Credit Rating
                The issuer is a participant in the  
                Shareholder Value Creation Program
                No data available
                Financials
                The issuer is a participant in the  
                Shareholder Value Creation Program
                Parameter
                Revenues
                EBITDA
                EBITDA Margin
                Net Profit (Loss)
                Earnings per share in reporting currency
                Net Cash Flow from Operating Activities
                Capital Expenditures
                Free Cash Flow
                Net Debt
                Net Debt / EBITDA
                ROE
                2025
                2024
                2023
                2022
                37,574,035 тыс. руб.
                21,448,519 тыс. руб.
                15,842,029 тыс. руб.
                13,479,612 тыс. руб.
                15,269,777 тыс. руб.
                8,228,985 тыс. руб.
                6,281,470 тыс. руб.
                5,826,944 тыс. руб.
                40.64%
                38.4%
                39.7%
                43.23%
                7,167,850 тыс. руб.
                2,875,644 тыс. руб.
                2,968,815 тыс. руб.
                3,974,722 тыс. руб.
                35.26
                13.94
                14.95
                -
                267,427 тыс. руб.
                92,984 тыс. руб.
                -1,191,102 тыс. руб.
                2,961,815 тыс. руб.
                4,556,488 тыс. руб.
                4,062,861 тыс. руб.
                4,422,179 тыс. руб.
                6,645,351 тыс. руб.
                -4,289,060 тыс. руб.
                -3,969,876 тыс. руб.
                -5,613,281 тыс. руб.
                -3,683,536 тыс. руб.
                25,146,796 тыс. руб.
                16,904,529 тыс. руб.
                16,033,896 тыс. руб.
                9,353,863 тыс. руб.
                1.65
                2.05
                2.6
                1.61
                31%
                18%
                25%
                46%
                Revenues
                2025
                37,574,035 тыс. руб.
                2024
                21,448,519 тыс. руб.
                2023
                15,842,029 тыс. руб.
                2022
                13,479,612 тыс. руб.
                EBITDA
                2025
                15,269,777 тыс. руб.
                2024
                8,228,985 тыс. руб.
                2023
                6,281,470 тыс. руб.
                2022
                5,826,944 тыс. руб.
                EBITDA Margin
                2025
                40.64%
                2024
                38.4%
                2023
                39.7%
                2022
                43.23%
                Net Profit (Loss)
                2025
                7,167,850 тыс. руб.
                2024
                2,875,644 тыс. руб.
                2023
                2,968,815 тыс. руб.
                2022
                3,974,722 тыс. руб.
                Earnings per share in reporting currency
                2025
                35.26
                2024
                13.94
                2023
                14.95
                2022
                -
                Net Cash Flow from Operating Activities
                2025
                267,427 тыс. руб.
                2024
                92,984 тыс. руб.
                2023
                -1,191,102 тыс. руб.
                2022
                2,961,815 тыс. руб.
                Capital Expenditures
                2025
                4,556,488 тыс. руб.
                2024
                4,062,861 тыс. руб.
                2023
                4,422,179 тыс. руб.
                2022
                6,645,351 тыс. руб.
                Free Cash Flow
                2025
                -4,289,060 тыс. руб.
                2024
                -3,969,876 тыс. руб.
                2023
                -5,613,281 тыс. руб.
                2022
                -3,683,536 тыс. руб.
                Net Debt
                2025
                25,146,796 тыс. руб.
                2024
                16,904,529 тыс. руб.
                2023
                16,033,896 тыс. руб.
                2022
                9,353,863 тыс. руб.
                Net Debt / EBITDA
                2025
                1.65
                2024
                2.05
                2023
                2.6
                2022
                1.61
                ROE
                2025
                31%
                2024
                18%
                2023
                25%
                2022
                46%

                The sources of company data are the securities offering prospectus, issuer report, and IFRS financial statements. The above figures are calculated by the companies themselves and disclosed in the aforementioned documents.

                Corporate Information Center data is provided with a delay of up to 24 hours. All information about securities and issuers is available

                here.

                Investor Help

                Moscow
                Exchange
                School
                Free stock trading course for beginners
                Learn more
                Moscow
                Exchange
                School
                Stock investment analysis course
                Learn more
                Interactive
                Trading
                Calendar
                Schedules of trading and settlement on MOEX's markets
                Go

                Dear website visitors, to submit a suggestion or ask a question, please use the feedback form. We value your opinion and will carefully review all inquiries. Where possible, we will acknowledge receipt of your message and provide a written response. In the event of substantiated and material complaints, the Exchange, together with the Expert Councils, will take steps to develop and implement appropriate changes.​

                -
                RUB

                -

                - RUB
                -
                Trading data is displayed with a delay of 15 minutes
                Buy
                Open a brokerage account with our partners to buy securities